How DPP-4 inhibitor attenuates the activation of the S6K1 in the setting of overnutrition- and obesity-induced INS resistance as well as its relation to β-cell function is yet fully elucidated. This evidence concerns the gene RPS6KB1 and obesity due to melanocortin 4 receptor deficiency.